1. Home
  2. Analysis
  3. Luxiq
  4. Cipro

Luxiq and Cipro drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Luxiq (betamethasone valerate) and Cipro (ciprofloxacin hydrochloride). Common drug interactions include injury among females.

The phase IV clinical study analyzes what interactions people have when they take Luxiq and Cipro. It is created by eHealthMe based on reports of 14 people who take the same drugs from the FDA, and is updated regularly.

What is Luxiq?

Luxiq has active ingredients of betamethasone valerate. eHealthMe is studying from 272 Luxiq users. Check the latest studies of Luxiq.

What is Cipro?

Cipro has active ingredients of ciprofloxacin hydrochloride. It is often used in urinary tract infection. eHealthMe is studying from 35,126 Cipro users. Check the latest studies of Cipro.

On Jul, 11, 2026

14 people who take Luxiq and Cipro together, and have interactions are studied.

Luxiq and Cipro drug interactions.

What are the common drug interactions of Luxiq and Cipro, by gender? *:

female:

  1. Injury
  2. Alopecia (absence of hair from areas of the body)
  3. Otitis externa (external ear infection)
  4. Scar
  5. Breast cancer
  6. Lymphadenopathy (disease or enlargement of lymph nodes)
  7. Ear pain
  8. Lymphoma (cancer that begins in immune system cells)
  9. Joint stiffness
  10. Lymphoedema (localized fluid retention and tissue swelling)

male:

n/a

What are the common drug interactions of Luxiq and Cipro, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

  1. Alopecia (absence of hair from areas of the body)
  2. Anaemia (lack of blood)
  3. Arthralgia (joint pain)
  4. Brain compression
  5. Breast cancer stage iii
  6. Breast fibrosis (the thickening and scarring of connective tissue, usually as a result of injury in breast)
  7. Breast inflammation
  8. Cerebellar infarction (impaired blood circulation to cerebellum)
  9. Dental caries
  10. Dermoid cyst (an abnormal growth (teratoma) containing epidermis, hair follicles, and sebaceous glands)

30-39:

n/a

40-49:

  1. Injury
  2. Alopecia (absence of hair from areas of the body)
  3. Lymphadenopathy (disease or enlargement of lymph nodes)
  4. Oral disorder (mouth disease)
  5. Otitis externa (external ear infection)
  6. Scar
  7. Ear pain
  8. Lymphoma (cancer that begins in immune system cells)
  9. Ejection fraction decreased (systolic heart failure)
  10. Joint stiffness

50-59:

n/a

60+:

n/a

What are the existing conditions these people have? *

  1. Eczema (patches of skin become rough and inflamed, with itching and bleeding blisters): 11 people, 78.57%
  2. Oral Disorder (mouth disease): 8 people, 57.14%
  3. Bacteraemia (presence of bacteria in the blood): 1 person, 7.14%

* Approximation only. Some reports may have incomplete information.

Do you take Luxiq and Cipro?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Luxiq and Cipro:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Luxiq:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Cipro:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Luxiq and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Cipro and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on betamethasone valerate and ciprofloxacin hydrochloride (the active ingredients of Luxiq and Cipro, respectively), and Luxiq and Cipro (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe:

© 2026 eHealthMe.com. All rights reserved. Use of this site constitutes acceptance of eHealthMe.com's terms of service and privacy policy.